Funded Grants
PI Name |
Organization | Title | Project Number | Fiscal Year | Major Program/Research Group |
|---|---|---|---|---|---|
| Buelow, Hannes Erich | Albert Einstein College Of Medicine | A Fluorescence-Based High-Throughput Platform for Glycotyping the Hematopoietic Cell Lineage | 1U01CA241981-01 | 2019 | Cancer Biomarkers |
| Califano, Joseph A | University Of California, San Diego | Optimizing an assay for high risk HPV DNA in body fluids | 5UH3CA211396-04 | 2020 | Cancer Biomarkers |
| Cantuaria, Guilherme | Northside Hospital Atlanta | Georgia NCI Community Oncology Research Program (GA NCORP) | 2UG1CA189997-06 | 2019 | Community Oncology and Prevention Trials, NCI Community Oncology Research Program, NCORP Community Sites |
| Cao, Lei | Ohio State University | Cancer prevention and treatment by activation of a brain-adipocyte axis | 5R01CA166590-08 | 2020 | Chemopreventive Agent Development |
| Cao, Yin | Washington University | Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia | 1R37CA246175-01A1 | 2020 | Gastrointestinal and Other Cancers |
| Carlson, Jay W | Ozark Health Ventures, Llc | Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) | 2UG1CA189822-06 | 2019 | Community Oncology and Prevention Trials, NCI Community Oncology Research Program, NCORP Community Sites |
| Carter, Bob S | Massachusetts General Hospital | Standardized Molecular Analyses of Glioma EVs | 1R01CA237500-01A1 | 2020 | Cancer Biomarkers, Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection |
| Carter, Bob S | Massachusetts General Hospital | Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas | 5U01CA230697-02 | 2019 | Cancer Biomarkers, Liquid Biopsy Consortium |
| Casero, Robert A. | Johns Hopkins University | Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target | 5R01CA204345-05 | 2020 | Chemopreventive Agent Development |
| Castle, Philip E | Albert Einstein College Of Medicine | A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical-Cancer Risk Reduction in HIV+ Women living in Mozambique | 1R01CA239921-01A1 | 2020 | Breast and Gynecologic Cancer |
| Chak, Amitabh | Case Western Reserve University | Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma | 5U54CA163060-09 | 2020 | Gastrointestinal and Other Cancers, Barrett's Esophagus Translational Research Network |
| Chan, Andrew T | Massachusetts General Hospital | Inflammation and Colorectal Neoplasia | 5R01CA137178-10 | 2019 | Gastrointestinal and Other Cancers |
| Chan, Andrew T | Massachusetts General Hospital | Molecular Risk Stratification for Colonoscopic Surveillance | 5U01CA182367-05 | 2019 | Early Detection, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
| Chan, Daniel Wanyui | Johns Hopkins University | Clinical and Analytical Validation of Cancer Biomarkers | 5U24CA115102-15 | 2020 | Cancer Biomarkers, Early Detection Research Network, EDRN Biomarker Reference Lab |
| Chang, Eric C | Baylor College Of Medicine | A novel N-Ras pathway driving DCIS to basal-like breast cancer | 5R21CA226567-02 | 2019 | Chemopreventive Agent Development |